Main news


Influencers of COVID Vaccine Response in Dialysis Patients Among patients undergoing maintenance dialysis, chronic heart failure and hypoalbuminaemia were significantly associated with a poor humoral response at 3 months after completing three doses of the SARS-CoV-2 messenger RNA (mRNA) vaccine; however, no association was observed between haemodialysis-related variables and antibody response levels.



Fewer ECG Abnormalities in Early T2D With Combo Therapy In patients with type 2 diabetes (T2D) of less than 10 years' duration who were taking metformin monotherapy, ECG abnormalities — including evidence of cardiovascular autonomic neuropathy — were common and associated with cardiovascular risk factors. After adding one of four frequently used glucose-lowering agents to metformin, fewer major ECG changes occurred with liraglutide than with the other treatments.



Surgery Treats Hypertension in Patients With Adrenal Tumours In patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (MACS), adrenalectomy was well tolerated and enabled a reduction or cessation of hypertensive treatment while maintaining blood pressure within normal ranges.



Acute Myocarditis Riskier Than Unexplained Chest Pain Despite being younger and having fewer comorbidities, patients with acute myocarditis (AM) had a significantly higher risk for 30-day and long-term mortality than those with unexplained chest pain.



Effect of BMI on Cardiovascular Risk in Rheumatoid Arthritis Varies by Antibody Status and Biologic Use Body mass index (BMI) influenced cardiovascular risk in rheumatoid arthritis (RA), with the effects varying according to anti–citrullinated protein antibody (ACPA) status and use of biologics. BMI was inversely associated with lower cardiovascular risk in ACPA-negative patients on biologics.



Sleep Disorders Linked to Aortic Stenosis Having any sleep disorder was independently linked to a higher likelihood for developing aortic stenosis, although dyslipidemia appeared to be an important mediator of the risk.



Age of menopause, healthy lifestyle and cardiovascular disease in women: a prospective cohort study Menopause is a timely opportunity to screen for cardiovascular disease (CVD) and intervene with healthier lifestyles. Scientists investigated the association between premature/early menopause and the likelihood of CVD and whether a healthy lifestyle is associated with a lower likelihood of CVD in menopausal woman.



Few Women Screened for Diabetes, Dyslipidemia Postpartum Screening for cardiovascular risk factors after pregnancy-related hypertension or diabetes may be suboptimal during the year after giving birth, data indicated.



Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension Pulmonary endarterectomy (PEA) is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), while balloon pulmonary angioplasty (BPA) is an alternative for inoperable patients. We aimed to compare right ventricular (RV) remodelling and late survival after PEA and BPA.



Association between NT-proBNP levels and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a well-established biomarker in clinical practice, particularly for heart failure, but its role in predicting atrial fibrillation (AF) risk is not fully understood. This meta-analysis aimed to evaluate the association between NT-proBNP levels and AF incidence, and to explore the potential of NT-proBNP in enhancing AF risk prediction models.


APOE4 May Raise Brain Bleed Risk in Apixaban Users With AF
APOE4 May Raise Brain Bleed Risk in Apixaban Users With AF Carriers of the apolipoprotein E epsilon 4 (APOE ε4) allele had a threefold higher risk for intracranial hemorrhage (ICH) when taking apixaban for atrial fibrillation (AF) compared with noncarriers, a new study suggested.


Novel Algorithm Transforms Echocardiographic Assessment of Heart Filling Pressures
Novel Algorithm Transforms Echocardiographic Assessment of Heart Filling Pressures A new algorithm for estimating left ventricular filling pressure (LVFP) by echocardiography reduced indeterminate results to just two cases compared with 38 using previous guidelines, achieving 86% accuracy in 949 patients, a new study found. The algorithm showed particular improvement for patients with normal left ventricular ejection fraction (LVEF), while maintaining similar accuracy for cases of reduced LVEF.


Editorial Activity

cardiology book

Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss
Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss Ecnoglutide, a novel glucagon-like peptide-1 (GLP-1) receptor agonist, was significantly more effective than placebo for inducing weight loss in adults with overweight or obesity, based on data from more than 600 individuals.


The New Playbook for Ditching Dangerous Senior Meds
The New Playbook for Ditching Dangerous Senior Meds A new tool presented at the American Geriatrics Society (AGS) 2025 Annual Scientific Meeting may give clinicians practical and safer alternatives to risky medications for patients.


International Research in Cardiology 2010-2014
International Research in Cardiology 2010-2014 Dear colleagues!
The Cardioprogress Foundation presents the book «International Research in Cardiology», which includes the results of the most important international clinical trials presented in 2010-2024. The authors systematized studies in 21 sections, which include risk factors, antiplatelet and anticoagulant therapy, laboratory and instrumental diagnostics, arrhythmia, invasive cardiology, valvular heart diseases, intensive care in cardiology and more.


New Drug Combos Could Cut Heart Failure Mortality by 60%
New Drug Combos Could Cut Heart Failure Mortality by 60% Optimized treatment can reduce the mortality risk for chronic heart failure (HF) by as much as 60%. The role of appropriate drug combinations and rapid diagnosis was discussed at the 91st Annual German Society of Cardiovascular Medicine Annual Conference.


Dedicated to eternal memory
Dedicated to eternal memory Dear colleagues!
On these holidays, the Cardioprogress Foundation remembers the heroes of the Great Patriotic War, whose feat was immortalized in the hearts of their descendants.


Spanish Cardiologists Release Gender-Specific CV Guide
Spanish Cardiologists Release Gender-Specific CV Guide The Spanish Society of Cardiology (SEC) Working Group on Women and Cardiovascular Diseases (SEC-GT CVD in Women) and the Association of Preventive Cardiology have convened an interdisciplinary group of experts from various Spanish societies and associations issued SEC-approved clinical guidelines published in the English-language edition of the Revista Española de Cardiología journal, which is designed to help medical professionals. in the diagnosis and treatment of cardiovascular diseases in women, paying special attention to gender differences.


Risk Model Validates Finerenone Effect in Heart Failure
Risk Model Validates Finerenone Effect in Heart Failure The Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction (PREDICT-HFpEF) tool effectively stratified cardiovascular risk, with risk being higher in the highest than in the lowest score quintile. Finerenone was consistently effective across risk levels in patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), with a large absolute benefit observed in high-risk patients.


Muslim fasting from a medical point of view
Muslim fasting from a medical point of view Dear colleagues!
We offer you an article by Professor Mekhman N. Mamedov about medical aspects of muslim fasting and practical advice for applicants.